Security key
539319301
LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (LIXT)
CUSIP: 539319301
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 297,557
- Total 13F value
- $607,533
- Share change
- +69,280
- SEC-reported price per share
- $2.03
- Number of holders
- 10
- Value change
- +$138,617
- Number of buys
- 2
- Number of sells
- 3
- Shares outstanding
- 2,666,933
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q4 2024
Institutions
10
Top holders
10
LIXT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2025
Previous quarter: Q3 2024
LIXTE BIOTECHNOLOGY HOLDINGS, INC. SEC filings
LIXTE BIOTECHNOLOGY HOLDINGS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 539319301
Recent filing periods:
Ownership snapshot
Top reported holders of LIXT - LIXTE BIOTECHNOLOGY HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
HighTower Advisors, LLC
Disclosed value leader
Glenn Krinsky
Comparable rows
7/14
Latest evidence
30 Sep 2024
13F
3/4/5
Lead comparable stake: 3.7%
7 rows are not safely comparable across share classes.
Showing 1-6 of 14 holder rows.
Quick read
HighTower Advisors, LLC leads the comparable SEC ownership view at 3.7%.
7 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
HighTower Advisors, LLC
3.7%
FNY Investment Advisers, LLC
2.7%
Ethos Financial Group, LLC
0.93%
GEODE CAPITAL MANAGEMENT, LLC
0.64%
Tower Research Capital LLC (TRC)
0.08%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| HighTower Advisors, LLC |
13F
Company
|
3.7%
|
$186,000
99,432 shares
|
— | 30 Sep 2024 |
| FNY Investment Advisers, LLC |
13F
Company
|
2.7%
|
$139,000
71,638 shares
|
— | 30 Sep 2024 |
| Ethos Financial Group, LLC |
13F
Company
|
0.93%
|
$46,000
24,808 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.64%
|
$33,463
17,161 shares
|
— | 30 Sep 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0.08%
|
$3,946
2,110 shares
|
— | 30 Sep 2024 |
| UBS Group AG |
13F
Company
|
0.01%
|
$686
367 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
297,557
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
7
Q4 2024 holders
10
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend